Salemonline Journal

3D Printed Drug Market to Witness Increasing Growth $522 Million by 2030 at CAGR of 6.5% | Allied Market Research

 Breaking News
  • No posts were found

3D Printed Drug Market to Witness Increasing Growth $522 Million by 2030 at CAGR of 6.5% | Allied Market Research

September 15
04:06 2019
3D Printed Drug Market to Witness Increasing Growth $522 Million by 2030 at CAGR of 6.5% | Allied Market Research

3D Printed Drug Market
Dysphagia is more prevalent in geriatric population and children, which results in difficulty while swallowing. 3D printed drugs are gaining popularity, as FDA has passed a priority review voucher system for it. In addition, increase in geriatric population and technological advancement in 3D pointing procedures are expected to contribute towards the growth of the market.

Spritam is the only 3D printed drug available in the market since 2016 to treat epilepsy. The potential market for other 3D printed drugs (moderate growth scenario) is estimated to be $278 million in 2020, and would reach $522 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030. U.S. market holds the highest market share in 2020.

3D printed drugs are medications created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have porous structures that can disintegrate rapidly inside the mouth itself. Aprecia Pharmaceuticals Companys SPRITAM levetiracetam is the first 3D printed drug, which has been approved by the U.S. Food and Drug Administration (FDA) in August 2015.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/4508

 

Constant technological developments in 3D printing technique, rise in incidence of epilepsy cases, and increase in awareness about the 3D printing technology in the developing countries drive the growth of the market. However, lack of government regulations related to these drugs and adverse effects of 3D printed drugs are expected to limit the market growth.

The global 3D printed drugs market is analyzed based on forecast scenario such as low growth scenario, moderate growth scenario, and rapid growth scenario.

According to low growth scenario, the U.S. is anticipated to account for the highest market share in 2020, and rest ofNorth America market is expected to grow at the highest rate, registering the CAGR of 5.1% by 2030.

Europe is estimated to account for four-sevenths share in 2020, and is expected to dominate the market throughout the forecast period, due to presence of well-established healthcare systems and increase in prevalence of dysphagia. In addition, increase in adoption of 3D printed drugs is anticipated to provide new growth opportunities for the key players in the European market. However, Asia-Pacific is projected to grow at the highest growth rate during the analysis period, owing to increase in healthcare expenditure, rise in awareness related to 3D printing technique, presence of large patient pool, and developments in healthcare infrastructure.

Key Findings of 3D Printed Drugs Market:

  • In North America, the U.S. is anticipated to dominate the market in 2020, whereas rest of North America is projected to grow at the highest CAGR during the forecast period.
  • Germany was the major shareholder in the European 3D printed drugs market in 2016.
  • Asia-Pacific is expected to register the highest growth rate in future.
  • Australia is expected to grow at the highest CAGR in the Asia-Pacific 3D printed drugs market.

 

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4508

 

Leading market players: –

The key players profiled in this report include Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, and FabRx Ltd.

The organizations engaged in the research of 3D printed drugs included in this report are UCL School of Pharmacy,University of Glasgow, University College London, The University of Nottingham, and National University of Singapore.

Similar Reports:

 

Drug Screening Market – Global Opportunity Analysis and Industry Forecast, 2017-2023

           

Drugs and Diagnostics for Hematological Disorders Market- Global Opportunity Analysis and Industry Forecast, 2019-2026

 

 

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry

Media Contact
Company Name: Allied Market Research
Contact Person: David Correa
Email: Send Email
Phone: +1-800-792-5285
Address:5933 NE Win Sivers Drive #205
City: Portland
State: OR 97220
Country: United States
Website: www.alliedmarketresearch.com/3d-printed-drugs-market